Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1239526

Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later


Prguda-Mujić, Jasminka; Hasanić, Osman; Bešić, Larisa; Ašić, Adna; Halilović, Sabina; Ćesić, Aida Kulo; Ljevaković, Neira; Muminović, Fildesa; Huseinović, Šukrija; Ler, Daria et al.
Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later // PLoS One, 17 (2022), 3; e0265431, 11 doi:10.1371/journal.pone.0265431 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1239526 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later

Autori
Prguda-Mujić, Jasminka ; Hasanić, Osman ; Bešić, Larisa ; Ašić, Adna ; Halilović, Sabina ; Ćesić, Aida Kulo ; Ljevaković, Neira ; Muminović, Fildesa ; Huseinović, Šukrija ; Ler, Daria ; Salihefendić, Lana ; Konjhodžić, Rijad ; Primorac, Dragan ; Marjanović, Damir

Izvornik
PLoS One (1932-6203) 17 (2022), 3; E0265431, 11

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
SARS-CoV-2 antibodies ; seropositive prevalence

Sažetak
Background: Serostudies are important resources when following pandemics and predicting their further spread, as well as determining the length of protection against reinfection and vaccine development. The aim of this study was to update data on the prevalence of seropositive individuals in Canton Sarajevo, Bosnia and Herzegovina (B&H) from September 2020 to May 2021. Methods: Anti- SARS-CoV-2 antibodies were quantified using an electrochemiluminescence immunoassay. Results: Compared to the period April-July 2020, when anti- SARS-CoV-2 antibodies were detected in 3.77% of samples, one year later (May 2021) the estimated percentage within the same population of the urban Canton Sarajevo was 29.9% (5, 406/18, 066). Of all anti-SARS-CoV-2 Ig-positive individuals, 53.27% were men, and 69.00% were of 50 years of age or younger. Also, the current update found the individuals 50 years of age or younger to be more frequently anti-SARS-CoV-2 Ig positive compared to older individuals. On the other hand, higher median anti-SARS-CoV-2 Ig levels were found in individuals > 50 years old than in younger individuals, as well as in men compared to women. Seropositivity gradually increased from September 2020 to May 2021, with the lowest frequency of positive cases (3.5%) observed in September 2020, and the highest frequency (77.7%) in January 2021. Conclusion: Our results provided important seroprevalence data that could help in planning restrictive local public health measures to protect the population of Sarajevo Canton, especially considering that at the time of the study the vaccines were virtually inaccessible to the general population not belonging to any of the high-priority groups for vaccination.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Split

Profili:

Avatar Url Dragan Primorac (autor)

Avatar Url Damir Marjanović (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Prguda-Mujić, Jasminka; Hasanić, Osman; Bešić, Larisa; Ašić, Adna; Halilović, Sabina; Ćesić, Aida Kulo; Ljevaković, Neira; Muminović, Fildesa; Huseinović, Šukrija; Ler, Daria et al.
Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later // PLoS One, 17 (2022), 3; e0265431, 11 doi:10.1371/journal.pone.0265431 (međunarodna recenzija, članak, znanstveni)
Prguda-Mujić, J., Hasanić, O., Bešić, L., Ašić, A., Halilović, S., Ćesić, A., Ljevaković, N., Muminović, F., Huseinović, Š. & Ler, D. (2022) Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later. PLoS One, 17 (3), e0265431, 11 doi:10.1371/journal.pone.0265431.
@article{article, author = {Prguda-Muji\'{c}, Jasminka and Hasani\'{c}, Osman and Be\v{s}i\'{c}, Larisa and A\v{s}i\'{c}, Adna and Halilovi\'{c}, Sabina and \'{C}esi\'{c}, Aida Kulo and Ljevakovi\'{c}, Neira and Muminovi\'{c}, Fildesa and Huseinovi\'{c}, \v{S}ukrija and Ler, Daria and Salihefendi\'{c}, Lana and Konjhod\v{z}i\'{c}, Rijad and Primorac, Dragan and Marjanovi\'{c}, Damir}, year = {2022}, pages = {11}, DOI = {10.1371/journal.pone.0265431}, chapter = {e0265431}, keywords = {SARS-CoV-2 antibodies, seropositive prevalence}, journal = {PLoS One}, doi = {10.1371/journal.pone.0265431}, volume = {17}, number = {3}, issn = {1932-6203}, title = {Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later}, keyword = {SARS-CoV-2 antibodies, seropositive prevalence}, chapternumber = {e0265431} }
@article{article, author = {Prguda-Muji\'{c}, Jasminka and Hasani\'{c}, Osman and Be\v{s}i\'{c}, Larisa and A\v{s}i\'{c}, Adna and Halilovi\'{c}, Sabina and \'{C}esi\'{c}, Aida Kulo and Ljevakovi\'{c}, Neira and Muminovi\'{c}, Fildesa and Huseinovi\'{c}, \v{S}ukrija and Ler, Daria and Salihefendi\'{c}, Lana and Konjhod\v{z}i\'{c}, Rijad and Primorac, Dragan and Marjanovi\'{c}, Damir}, year = {2022}, pages = {11}, DOI = {10.1371/journal.pone.0265431}, chapter = {e0265431}, keywords = {SARS-CoV-2 antibodies, seropositive prevalence}, journal = {PLoS One}, doi = {10.1371/journal.pone.0265431}, volume = {17}, number = {3}, issn = {1932-6203}, title = {Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later}, keyword = {SARS-CoV-2 antibodies, seropositive prevalence}, chapternumber = {e0265431} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font